Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intranasal desmopressin for prevention of bleeding complications after kidney biopsy in renal failure
IRCT20201019049075N1Phase 3Completed
- Sponsor
- Shiraz University of Medical Sciences
- Start
- Dec 2019
- Modality
- Small Molecules, Peptides
- Countries
- 1
01
Overview
Phase 3, double-blind trial of desmopressin in acute kidney failure (AKF) (2 arms), sponsored by Shiraz University of Medical Sciences. Primary endpoints: Proportion of patients who develop hematoma and Proportion of patients who develop hematuria. Started Dec 2019; status: completed.
02
Drugs
desmopressin
03
Conditions
acute kidney failure (AKF)
Beyond the preview
Go deeper on IRCT20201019049075N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20201019049075N1.